Trade Mark Journal No.2025/044 31 October 2025

WO0000001881723 (5)

Office of origin: United States of America

Date of International Registration:11 September 2025
Date of designation in the UK: 11 September 2025
Image for mark 1881723 AYMFORI

International priority date claimed: 12 May 2025 (United States of America) (99180944)
Class 5
Pharmaceutical preparations for the treatment of obesity and metabolic diseases and disorders.

Rhythm Pharmaceuticals, Inc.

Representative: Peter G. Byrne Pranger Law PC, 88 Guy Place, Suite 405 , San Francisco CA 94105, UNITED STATES OF AMERICA